|
|
 |
|
Viewing report
|
|
|
|
Global Gene Therapy Market Analysis
RNCOS E-Services Private Limited, April 2012, Pages: 120
In the past few years, gene therapy has come a long way to become one of the most sought after methods to develop a treatment. Despite being at a nascent stage in terms of revenue generation, the gene therapy market holds tremendous growth potential. As per a new estimation, carried out in our latest study, the global gene therapy industry will reach US$ 325 Million by the end of 2015 as new products, especially those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.
According to our new research report, “Global Gene Therapy Market Analysis”, major market players are developing gene therapy-based products using the adenoviral vectors. We found that the majority of the drugs using the adenoviral vectors are in the phase I/II clinical stages. In this context, the study provides a comprehensive overview of the different vectors in the gene therapy market, and talks about major products in the pipeline and their development phase.
Through in-depth and prudent analysis of the developments taking place at the global level, we have observed that the market is presently dominated by oncology applications. A large number of companies and academic institutions are developing products, targeting different types of cancer. Other therapeutic areas, such as genetic disorder and neurological diseases are also occupying enough space in the product pipeline. An effective analysis of the key therapeutic areas has been included in our report.
The report studies how trends and drivers, including gene silencing, advanced therapies and increased use of viral vectors, among others, will propel the industry’s growth. The study of key geographies revealed that the US, Europe, Canada, China, and Japan are the major markets exhibiting healthy growth rates. It also highlighted that the highest growth rate in the developing countries’ gene therapy market is likely to be observed for the treatment of cancer, followed by infectious diseases, like AIDS. Our comprehensive research report also looks into the profiles of key market players, including AnGes MG and Ark Therapeutics, to provide an objective view of the global gene therapy market to clients.
Customers who bought this item also bought
Molecular Diagnostics - Technologies, Markets and Companies
Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for Approved Products Reflects a Pessimistic R&D Future
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
Regenerative Medicine Markets
Nitric Oxide - Therapeutics, Markets and Companies
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
Neurostimulation - Global Strategic Business Report
Therapeutic Apheresis - Global Strategic Business Report
|
|
|
|
